Mucus Relief DM Max

Product NDC
55910-338
Requested package NDC
55910-338-09
11-digit product format
559100338
Labeler code
55910
Product ID
55910-338_d6d0e5a7-0831-4b12-b96a-50897312cb0f
Type
HUMAN OTC DRUG
Nonproprietary name
Dextromethorphan HBr, Guaifenesin
Dosage form
LIQUID
Route
ORAL
Labeler
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2015-04-30
Marketing end
2021-12-30
Substance
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Active strength
20 mg/20mL; mg/20mL
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage55910-33855910-338-09DDiscontinued by firm2026-10-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
DEXTROMETHORPHAN HYDROBROMIDEACTIVE INGREDIENT9D2RTI9KYHMUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
GUAIFENESINACTIVE INGREDIENT495W7451VQMUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
DEXTROMETHORPHANACTIVE MOIETY7355X3ROTSMUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
GUAIFENESINACTIVE MOIETY495W7451VQMUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSLMUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
D&C RED NO. 33INACTIVE INGREDIENT9DBA0SBB0LMUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
DEXTROSEINACTIVE INGREDIENTIY9XDZ35W2MUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOAMUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXMUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TMUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
POTASSIUM SORBATEINACTIVE INGREDIENT1VPU26JZZ4MUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3MUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHMUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
SACCHARIN SODIUMINACTIVE INGREDIENTSB8ZUX40TYMUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32IMUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
SUCRALOSEINACTIVE INGREDIENT96K6UQ3ZD4MUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
WATERINACTIVE INGREDIENT059QF0KO0RMUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEEMUCUS RELIEF DM MAX MAXIMUM STRENGTH FAST ACTING (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
55910-338-0955910033809266 mL in 1 BOTTLE, PLASTIC (55910-338-09) 266 ml2015-04-302021-12-30NoNoCurrent